ESSA Pharma Inc. , a clinical-stage pharmaceutical company focused on the development of novel small molecule drugs for the treatment of...
Read moreAdamas Pharmaceuticals, Inc. announced that the U.S. FDA has approved GOCOVRI extended release capsules (previously ADS-5102) for treatment of dyskinesia...
Read moreSanofi announced that the U.S. FDA granted tentative approval for Admelog® (insulin lispro injection) 100 Units/mL, a rapid-acting human insulin...
Read moreJazz Pharmaceuticals plc and ImmunoGen, Inc. announced that the companies have entered into a collaboration and option agreement granting Jazz...
Read moreAntibe Therapeutics has announced that it has received approval from Health Canada to initiate a Phase 2, double-blind, gastrointestinal endoscopy...
Read moreGenentech, a member of the Roche Group , announced that the U.S. FDA has accepted the company’s supplemental Biologics License...
Read moreThe Phase 3 GENESIS trial is aimed at evaluating the safety, tolerability and efficacy of the combination treatment of BL-8040...
Read moreBoehringer Ingelheim and pharmaceutical company Pharmaxis announce that Boehringer Ingelheim has initiated a European and North American Phase IIa trial...
Read moreAurobindo Pharma Limited is pleased to announce that the company has received tentative approval from the U.S. FDA under the...
Read moreSamsung Bioepis Co., Ltd. announced that it has entered into a strategic collaboration agreement with Takeda Pharmaceutical Company Limited to...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.